Clinical Trial Update: Clinical and Economic Burden of Bleeding Events in Patients in the UK With Non-valvular Atrial Fibrillation Treated With Vitamin k Antagonists

View source ↗

Summary

A completed UK study assesses the clinical and economic burden of bleeding events in patients with non-valvular atrial fibrillation treated with vitamin K antag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Atrial Fibrillation | Status: COMPLETED